ÂÜÀòÂÒÂ×

Danielle Egan holds an M.Sc in Neuroscience from Trinity College Dublin and a B.Sc in Physiology from University College Dublin. Currently, Danielle serves as the Manager of Business Development, Investor Relations, and Corporate Communications at Eupraxia Pharmaceuticals Inc. since May 2023. Previously, Danielle held roles at NervGen Pharma Corp. as Manager of Business Development from October 2019 to April 2023, and at LifeSciences BC in Events & Membership. Additional experience includes working in Business Development at MotionHall and Aquinox Pharmaceuticals, where Danielle focused on market research, due diligence management, and financial modeling. Early career positions include Central Scientific Field Interviewer at Simon Fraser University, Clinical Data Coordinator II at ICON plc, and Senior Clinical Data Coordinator at Quintiles.